Doxa AB
STO:DOXA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tanger Factory Outlet Centers Inc
NYSE:SKT
|
US |
Doxa AB
Net Income
Doxa AB
Net Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Doxa AB
STO:DOXA
|
Net Income
-kr151.2m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-63%
|
CAGR 10-Years
-25%
|
|
|
O
|
OssDsign AB
STO:OSSD
|
Net Income
-kr46.8m
|
CAGR 3-Years
22%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Xvivo Perfusion AB
STO:XVIVO
|
Net Income
kr38.6m
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
18%
|
|
|
Bactiguard Holding AB
STO:BACTI B
|
Net Income
-kr7.8m
|
CAGR 3-Years
47%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
V
|
Vimian Group AB
STO:VIMIAN
|
Net Income
€66.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
S2Medical AB (publ)
STO:S2M
|
Net Income
-kr2.7m
|
CAGR 3-Years
54%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Doxa AB
Glance View
Doxa AB engages in the development, manufacture, and commercialization of bioceramic dental products. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2014-04-07. The firm develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
See Also
What is Doxa AB's Net Income?
Net Income
-151.2m
SEK
Based on the financial report for Dec 31, 2025, Doxa AB's Net Income amounts to -151.2m SEK.
What is Doxa AB's Net Income growth rate?
Net Income CAGR 10Y
-25%
Over the last year, the Net Income growth was 91%. The average annual Net Income growth rates for Doxa AB have been -49% over the past three years , -63% over the past five years , and -25% over the past ten years .
